Related content

Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

By Mahon James  

Calcified Tissue International, Vol. 88, Iss. 6, 2011-06 ,pp. : 530-530

Springer Publishing Company

Access to resources Recommend Favorite

Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

By Hampson Geeta  

Calcified Tissue International, Vol. 88, Iss. 6, 2011-06 ,pp. : 531-531

Springer Publishing Company

Access to resources Recommend Favorite

Impact of Treatments for Postmenopausal Osteoporosis (Bisphosphonates, Parathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review

By Gallacher S.  

Calcified Tissue International, Vol. 87, Iss. 6, 2010-12 ,pp. : 469-484

Springer Publishing Company

Access to resources Recommend Favorite

Sequential Treatment with Intermittent Low-Dose Human Parathyroid Hormone (1-34) and Bisphosphonate Enhances Large-Size Skeletal Reconstruction by Vascularized Bone Transplantation

By Hashimoto Takahiro   Shigetomi Mitsunori   Ohno Teruyasu   Matsunaga Tsunemitsu   Muramatsu Keiichi   Tanaka Hiroshi   Sugiyama Toshihiro   Taguchi Toshihiko  

Calcified Tissue International, Vol. 81, Iss. 3, 2007-09 ,pp. : 232-239

Springer Publishing Company

Access to resources Recommend Favorite

Association of Oxidative Stress with Postmenopausal Osteoporosis and the Effects of Hydrogen Peroxide on Osteoclast Formation in Human Bone Marrow Cell Cultures

By Baek Ki   Oh Ki   Lee Won   Lee Seong   Kim Mee   Kwon Hyuk   Rhee Eun   Han Je   Song Ki   Cha Bong   Lee Kwang   Kang Moo  

Calcified Tissue International, Vol. 87, Iss. 3, 2010-09 ,pp. : 226-235

Springer Publishing Company

Access to resources Recommend Favorite